Correlation Between RAPT Therapeutics and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both RAPT Therapeutics and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAPT Therapeutics and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RAPT Therapeutics and Syndax Pharmaceuticals, you can compare the effects of market volatilities on RAPT Therapeutics and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAPT Therapeutics with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAPT Therapeutics and Syndax Pharmaceuticals.
Diversification Opportunities for RAPT Therapeutics and Syndax Pharmaceuticals
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between RAPT and Syndax is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding RAPT Therapeutics and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and RAPT Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAPT Therapeutics are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of RAPT Therapeutics i.e., RAPT Therapeutics and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between RAPT Therapeutics and Syndax Pharmaceuticals
Given the investment horizon of 90 days RAPT Therapeutics is expected to under-perform the Syndax Pharmaceuticals. In addition to that, RAPT Therapeutics is 1.8 times more volatile than Syndax Pharmaceuticals. It trades about -0.21 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.06 per unit of volatility. If you would invest 1,894 in Syndax Pharmaceuticals on September 4, 2024 and sell it today you would lose (224.00) from holding Syndax Pharmaceuticals or give up 11.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
RAPT Therapeutics vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| RAPT Therapeutics |
| Syndax Pharmaceuticals |
RAPT Therapeutics and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RAPT Therapeutics and Syndax Pharmaceuticals
The main advantage of trading using opposite RAPT Therapeutics and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAPT Therapeutics position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| RAPT Therapeutics vs. Connect Biopharma Holdings | RAPT Therapeutics vs. Tyra Biosciences | RAPT Therapeutics vs. Xilio Development | RAPT Therapeutics vs. Mineralys Therapeutics, Common |
| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |